ModelEdge
Fusion Pharmaceuticals Inc.
FUSN
Filing type
8-K
Filing date
Jun 3, 2024
Updated
Jun 4, 2024 ยท 2:18 PM

Filing

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events

Exhibits

EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other EventsGRAPHICGraphic